Augmented ability of spleen cells to produce interferons and prevention from lethal infection of herpes simplex virus in mice orally treated with Entrococcus faecalis preparation, FK-23

Yakugaku Zasshi

Volumn 116, Issue 4, 1996, Pages 323-328

  Nohmi, Takao ^a   Abe, Shigeru ^b   Katoh, Masahiro ^b   Yamamoto, Tetsuro ^a   Yamaguchi, Hideyo ^b  

^a Nichinichi Pharmaceutical Co Ltd   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

cyclophosphamide; Enterococcus faecalis; herpes simplex virus; interferon; interferon inducer; spleen cell

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOPHOSPHAMIDE; FK 23; IMMUNOSTIMULATING AGENT; INTERFERON; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; DRUG MECHANISM; ENTEROCOCCUS; HERPES SIMPLEX; IMMUNOMODULATION; INTERFERON PRODUCTION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; SPLEEN CELL; VIRUS VIRULENCE;

EID: 0029884410     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi1947.116.4_323     Document Type: Article

References (13)

1. Satonaka K., Ohashi K., Nohmi T., Yamamoto T., Abe S., Uchida K., Yamaguchi H., Microbiol. Immunol., 40, 217 (1996).
2. Harada Y., Kurokawa E., Endo H., Kimura T., Saito M., Sugawara Y., Irie H., Ito K., Fujii M., Shimizu Y., Kumagai K., Microbiol. Immunol., 33, 467 (1989).
3. Irie H., Harada Y., Yoshihashi H., Kimura T., Kojima M., Kataoka M., Saito M., Sugawara Y., Mon W., Arch. Viol., 105, 247 (1989).
4. Shimizu F., Satoh J., Tada M., Kumagai K., Infect. Immun., 22, 752 (1978).
5. Havell E. A., Spitalny G. L., Patel P. J., J. Exp. Med., 156, 112 (1982).
6. Belardelli F., Gessani S., Proitti E., Locardi C., Borghi P., Watanabe Y., Kawabe Y., Gresser I., J. Gen. Virol., 68, 2203 (1987).
7. SAS Institute Inc., P-179, Additional SAS/STAT Procedures Release 6.03, SAS Institute Inc., Cary, N. C., 1988.
8. Gobi A. E., Funa K., Aim G. V., J. Immunol., 10, 3605 (1988).